{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:38:44Z","timestamp":1781311124719,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":3622,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/j.1600-6143.2012.04328.x","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T02:16:49Z","timestamp":1353464209000},"page":"192-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Treatment of Steroid-Resistant Acute Renal Allograft Rejection With Alemtuzumab"],"prefix":"10.1016","volume":"13","author":[{"given":"M.W.F.","family":"van den Hoogen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"van Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Weimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.B.","family":"Hilbrands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2012.04328.x_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1517\/14712598.2012.689278","article-title":"Anti-T cell antibodies for the treatment of acute rejection after renal transplantation","volume":"12","author":"van den Hoogen","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.tp.0000215178.72344.9d","article-title":"Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: A systematic review of randomized trial data","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.transproceed.2010.11.018","article-title":"Treatment of first acute rejection episode: Systematic review of level I evidence","volume":"43","author":"Uslu","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1592\/phco.26.12.1771","article-title":"Rabbit antithymocyte globulin induction therapy in adult renal transplantation","volume":"26","author":"Hardinger","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2165\/00003495-200363120-00003","article-title":"Alemtuzumab","volume":"63","author":"Frampton","year":"2003","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib6","first-page":"759","article-title":"Campath and renal transplant rejection","volume":"18","author":"Thomas","year":"2004","journal-title":"ClinTransplant"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib7","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.transproceed.2005.03.042","article-title":"Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients","volume":"37","author":"Csapo","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1399-3046.2011.01615.x","article-title":"Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection","volume":"16","author":"Upadhyay","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.transproceed.2004.12.019","article-title":"Reversal of acute cellular rejection after renal transplantation with Campath-1H","volume":"37","author":"Basu","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/TP.0b013e31819d3353","article-title":"Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: Long-term follow-up","volume":"87","author":"Clatworthy","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1111\/j.1600-6143.2012.04328.x_bib12","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1385\/MO:19:2S:S57","article-title":"Future prospects for alemtuzumab (MabCampath)","volume":"19","author":"Rai","year":"2002","journal-title":"Med Oncol"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.tp.0000191940.13473.59","article-title":"T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients","volume":"81","author":"Bloom","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1600-6143.2008.02273.x","article-title":"Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: Results of a prospective randomized trial","volume":"8","author":"Margreiter","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04328.x_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/510388","article-title":"Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2012.04328.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522257827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522257827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2012.04328.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:58:07Z","timestamp":1761627487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522257827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1600613522257827"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04328.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Steroid-Resistant Acute Renal Allograft Rejection With Alemtuzumab","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04328.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}